{"id":"https://openalex.org/W2804447785","doi":"https://doi.org/10.1038/s41598-018-26187-w","title":"Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities","display_name":"Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities","publication_year":2018,"publication_date":"2018-05-11","ids":{"openalex":"https://openalex.org/W2804447785","doi":"https://doi.org/10.1038/s41598-018-26187-w","mag":"2804447785","pmid":"https://pubmed.ncbi.nlm.nih.gov/29773891","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5958109"},"language":"en","primary_location":{"id":"doi:10.1038/s41598-018-26187-w","doi":"https://doi.org/10.1038/s41598-018-26187-w","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-018-26187-w","pdf_url":"https://www.nature.com/articles/s41598-018-26187-w.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41598-018-26187-w.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078301959","display_name":"Vahid Farrokhi","orcid":"https://orcid.org/0000-0002-8820-8919","observed_orcids":["https://orcid.org/0000-0002-8820-8919"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vahid Farrokhi","raw_affiliation_strings":["Biomedicine Design, Worldwide Research and Development, Pfizer Inc., Andover, Massachusetts, 01810, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedicine Design, Worldwide Research and Development, Pfizer Inc., Andover, Massachusetts, 01810, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077177263","display_name":"J Chabot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey R. Chabot","raw_affiliation_strings":["Biomedicine Design, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedicine Design, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005706542","display_name":"Hendrik Neubert","orcid":"https://orcid.org/0000-0002-8476-5427","observed_orcids":["https://orcid.org/0000-0002-8476-5427"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hendrik Neubert","raw_affiliation_strings":["Biomedicine Design, Worldwide Research and Development, Pfizer Inc., Andover, Massachusetts, 01810, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedicine Design, Worldwide Research and Development, Pfizer Inc., Andover, Massachusetts, 01810, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038427328","display_name":"Zhiyong Yang","orcid":"https://orcid.org/0000-0003-0589-6224","observed_orcids":["https://orcid.org/0000-0003-0589-6224"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Zhiyong Yang","raw_affiliation_strings":["Inflammation and Immunology Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts, 02139, USA. zhiyong.yang@pfizer.com","Inflammation and Immunology Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts, 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inflammation and Immunology Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts, 02139, USA. zhiyong.yang@pfizer.com","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Inflammation and Immunology Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts, 02139, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5038427328"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":2690,"currency":"USD","value_usd":2690},"apc_paid":{"value":2690,"currency":"USD","value_usd":2690},"fwci":3.1913,"has_fulltext":true,"cited_by_count":46,"citation_normalized_percentile":{"value":0.91228495,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"8","issue":"1","first_page":"7781","last_page":"7781"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12110","display_name":"Bone and Dental Protein Studies","score":0.8695999979972839,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12110","display_name":"Bone and Dental Protein Studies","score":0.8695999979972839,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.062199998646974564,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.018699999898672104,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osteopontin","display_name":"osteopontin","score":1.0},{"id":"https://openalex.org/keywords/therapeutic-antibodies","display_name":"therapeutic antibodies","score":0.7049999833106995},{"id":"https://openalex.org/keywords/antibody-neutralization","display_name":"antibody neutralization","score":0.8769999742507935},{"id":"https://openalex.org/keywords/protein-turnover-rate","display_name":"protein turnover rate","score":0.9120000004768372},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7940000295639038},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9449999928474426},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-modeling","display_name":"pharmacokinetic-pharmacodynamic modeling","score":0.8669999837875366},{"id":"https://openalex.org/keywords/antibody-engineering","display_name":"antibody engineering","score":0.4620000123977661},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.7699999809265137},{"id":"https://openalex.org/keywords/cancer","display_name":"cancer","score":0.7900000214576721},{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.9110000133514404},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.33799999952316284}],"concepts":[{"id":"https://openalex.org/C2780804394","wikidata":"https://www.wikidata.org/wiki/Q411994","display_name":"Osteopontin","level":2,"score":0.8926751017570496},{"id":"https://openalex.org/C3019692148","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Therapeutic modalities","level":2,"score":0.6568147540092468},{"id":"https://openalex.org/C2779903281","wikidata":"https://www.wikidata.org/wiki/Q6888026","display_name":"Modalities","level":2,"score":0.6171868443489075},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.47297564148902893},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.4700941741466522},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4254956841468811},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4129367470741272},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3847159743309021},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23890581727027893},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19886139035224915},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1593364179134369},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005240","descriptor_name":"Feasibility Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053495","descriptor_name":"Osteopontin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D053495","descriptor_name":"Osteopontin","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D053495","descriptor_name":"Osteopontin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1038/s41598-018-26187-w","doi":"https://doi.org/10.1038/s41598-018-26187-w","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-018-26187-w","pdf_url":"https://www.nature.com/articles/s41598-018-26187-w.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4919822","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5958109","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5958109","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5958109","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sci Rep","raw_type":"Text"},{"id":"pmid:29773891","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29773891","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific reports","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:124251a9ea324b5999b85084878bc640","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/124251a9ea324b5999b85084878bc640","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Scientific Reports, Vol 8, Iss 1, Pp 1-7 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s41598-018-26187-w","doi":"https://doi.org/10.1038/s41598-018-26187-w","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-018-26187-w","pdf_url":"https://www.nature.com/articles/s41598-018-26187-w.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2804447785.pdf","grobid_xml":"https://content.openalex.org/works/W2804447785.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1977283269","https://openalex.org/W1994179117","https://openalex.org/W2004558229","https://openalex.org/W2006877529","https://openalex.org/W2017449311","https://openalex.org/W2024689470","https://openalex.org/W2035744669","https://openalex.org/W2037068771","https://openalex.org/W2038692658","https://openalex.org/W2041792934","https://openalex.org/W2042858467","https://openalex.org/W2050528333","https://openalex.org/W2051930920","https://openalex.org/W2057114015","https://openalex.org/W2062726330","https://openalex.org/W2080924071","https://openalex.org/W2082351772","https://openalex.org/W2099058664","https://openalex.org/W2106638848","https://openalex.org/W2112868959","https://openalex.org/W2122059694","https://openalex.org/W2158387300","https://openalex.org/W2158868913","https://openalex.org/W2159168546","https://openalex.org/W2165234873","https://openalex.org/W2168994208","https://openalex.org/W2175707361","https://openalex.org/W2298166996","https://openalex.org/W2319777633","https://openalex.org/W2331660568","https://openalex.org/W2477514514","https://openalex.org/W2514181786","https://openalex.org/W2567315309","https://openalex.org/W2766480523"],"related_works":["https://openalex.org/W3136815103","https://openalex.org/W7100343859","https://openalex.org/W2486001052","https://openalex.org/W2823553145","https://openalex.org/W7204599454","https://openalex.org/W2117381705","https://openalex.org/W4416041500","https://openalex.org/W4412572702","https://openalex.org/W2033985429","https://openalex.org/W2901768286"],"abstract_inverted_index":{"Osteopontin":[0],"is":[1,6],"a":[2,56,88,99,114],"secreted":[3],"glycophosphoprotein":[4],"that":[5,130,145],"highly":[7],"implicated":[8],"in":[9,55,87,97,121,170],"many":[10],"physiological":[11,94],"and":[12,25,43,106,138,189,195],"pathological":[13],"processes":[14],"such":[15,63],"as":[16,34,64,162,164],"biomineralization,":[17],"cell-mediated":[18],"immunity,":[19],"inflammation,":[20],"fibrosis,":[21],"cell":[22],"survival,":[23],"tumorigenesis":[24],"metastasis.":[26],"Antibodies":[27],"against":[28,174],"osteopontin":[29,53,83,131,175],"have":[30,48,182],"been":[31,76],"actively":[32],"pursued":[33],"potential":[35],"therapeutics":[36],"for":[37,103],"various":[38],"diseases":[39,62],"by":[40,126],"pharmaceutical":[41],"companies":[42],"academic":[44],"laboratories.":[45],"Many":[46],"studies":[47],"demonstrated":[49],"the":[50,80],"efficacy":[51],"of":[52,58,61,82,110,140],"inhibition":[54],"variety":[57],"preclinical":[59],"models":[60],"rheumatoid":[65],"arthritis,":[66],"cancer,":[67],"nonalcoholic":[68],"steatohepatitis,":[69],"but":[70],"clinical":[71,89],"utility":[72],"has":[73],"not":[74],"yet":[75],"demonstrated.":[77],"To":[78],"evaluate":[79],"feasibility":[81],"neutralization":[84],"with":[85,196],"antibodies":[86,151,173],"setting,":[90],"we":[91],"measured":[92],"its":[93,165],"turnover":[95],"rate":[96],"humans,":[98],"sensitive":[100],"parameter":[101],"required":[102],"mechanistic":[104],"pharmacokinetic":[105],"pharmacodynamic":[107],"(PK/PD)":[108],"modeling":[109,137],"biotherapeutics.":[111],"Results":[112],"from":[113],"stable":[115],"isotope-labelled":[116],"amino":[117],"acid":[118],"pulse-chase":[119],"study":[120],"healthy":[122],"human":[123],"subjects":[124],"followed":[125],"mass":[127],"spectrometry":[128],"showed":[129],"undergoes":[132],"very":[133,154],"rapid":[134],"turnover.":[135],"PK/PD":[136],"simulation":[139],"different":[141],"theoretical":[142],"scenarios":[143],"reveal":[144],"achieving":[146],"sufficient":[147],"target":[148],"coverage":[149],"using":[150],"can":[152],"be":[153,179,190],"challenging":[155],"mostly":[156],"due":[157],"to":[158,178,181],"osteopontin's":[159],"fast":[160],"turnover,":[161],"well":[163],"relatively":[166],"high":[167,193],"plasma":[168],"concentrations":[169],"human.":[171],"Therapeutic":[172],"would":[176],"need":[177],"engineered":[180],"much":[183],"extended":[184],"PK":[185],"than":[186],"conventional":[187],"antibodies,":[188],"administered":[191],"at":[192],"doses":[194],"short":[197],"dosing":[198],"intervals.":[199]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-06-01T00:00:00"}